NCT02480296View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions

Healthy

Interventions

DRUG

MYK-461

DRUG

Placebo

Placebo comparator

Trial Locations (1)

Unknown

Nucleus Network, Melbourne

Sponsors

Lead Sponsor

MyoKardia, Inc.

All Listed Sponsors

lead

MyoKardia, Inc.

INDUSTRY